$0.49
4.36% day before yesterday
Nasdaq, Sep 06, 10:10 pm CET
ISIN
US6901451079
Symbol
OM

Outset Medical Inc Stock price

$0.49
-3.03 86.11% 1M
-2.31 82.53% 6M
-4.92 90.96% YTD
-12.93 96.36% 1Y
-49.05 99.01% 3Y
-60.19 99.19% 5Y
-60.19 99.19% 10Y
Nasdaq, Closing price Fri, Sep 06 2024
-0.02 4.36%
ISIN
US6901451079
Symbol
OM
Sector

Key metrics

Market capitalization $25.48m
Enterprise Value $32.93m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.28
P/S ratio (TTM) P/S ratio 0.22
P/B ratio (TTM) P/B ratio 0.37
Revenue growth (TTM) Revenue growth -9.94%
Revenue (TTM) Revenue $116.43m
EBIT (operating result TTM) EBIT $-150.48m
Free Cash Flow (TTM) Free Cash Flow $-140.00m
Cash position $194.85m
EPS (TTM) EPS $-3.14
P/E forward negative
P/S forward 0.23
EV/Sales forward 0.30
Short interest 8.22%
Show more

Is Outset Medical Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Outset Medical Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Outset Medical Inc forecast:

4x Buy
50%
3x Hold
38%
1x Sell
13%

Analyst Opinions

8 Analysts have issued a Outset Medical Inc forecast:

Buy
50%
Hold
38%
Sell
13%

Financial data from Outset Medical Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
116 116
10% 10%
100%
- Direct Costs 84 84
21% 21%
72%
33 33
38% 38%
28%
- Selling and Administrative Expenses 126 126
4% 4%
108%
- Research and Development Expense 51 51
4% 4%
44%
-144 -144
10% 10%
-124%
- Depreciation and Amortization 6.16 6.16
7% 7%
5%
EBIT (Operating Income) EBIT -150 -150
10% 10%
-129%
Net Profit -159 -159
6% 6%
-137%

In millions USD.

Don't miss a Thing! We will send you all news about Outset Medical Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Outset Medical Inc Stock News

Neutral
PRNewsWire
about 10 hours ago
NEW YORK , Sept. 7, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Outset Medical, Inc. (NASDAQ: OM) between August 1, 2022 and August 7, 2024, both dates inclusive (the "Class Period").
Neutral
PRNewsWire
about 24 hours ago
LOS ANGELES , Sept. 6, 2024 /PRNewswire/ -- The Law Offices of Frank R.
Neutral
GlobeNewsWire
one day ago
SAN FRANCISCO, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Hagens Berman encourages Outset Medical (NASDAQ: OM) investors who suffered substantial losses to submit your losses now.
More Outset Medical Inc News

Company Profile

Outset Medical, Inc. is a medical technology company, which provides dialysis solutions to patients and healthcare providers. Its product Tablo Hemodialysis System (Tablo), offers technological advancement enabling novel, transformational dialysis care in acute and home settings. The company was founded in 2003 and is headquartered in San Jose, CA.

Head office United States
CEO Leslie Trigg
Employees 480
Founded 2003
Website www.outsetmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today